SLC2A1 and cancer: Interestingly, it was reported that miR-342-3p can regulate glycolysis by modulating the key metabolic enzymes by repressing the IGF-1R-associated PI3K/AKT/GLUT1 signaling pathway, which indicates its importance as a cancer metabolic regulator [98].